Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals
Margaret May(James Madison University), Jonathan A C Sterne(University of Bristol), Andrea Bregenzer(Inserm), Amy C. Justice(Yale University), Ole Kirk(University of Copenhagen), Marguerite Guiguet(Inserm), Jodie L. Guest(Emory University), Heidi M. Crane(University of Washington), M. John Gill(University of Calgary), Carolynne Schwarze‐Zander(University Hospital Bonn), Timothy R. Sterling(Vanderbilt University Medical Center), Antonella d’Arminio Monforte(University of Milan), Suzanne M Ingle(University of Bristol), Santiago Moreno(Universidad El Bosque), Cristina Tural(Universitat Autònoma de Barcelona), Colette Smit(Stichting HIV Monitoring), D. Neau(Hôpital Pellegrin), Kate Birnie(University of Bristol), Michael S Saag(Harborview Medical Center), Colette Smith(MRC Clinical Trials Unit at UCL)
Cited by 45
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k